IP Library Granted Patent US 9,414,903
Granted Patent B2
US 9,414,903 · App. 13/556,167 · Granted Aug 16, 2016

Pelvic implant system and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,414,903
App. No.
13/556,167
Granted
Aug 16, 2016
Kind
B2
Abstract

Systems and methods are provided and adapted to engage and pull (e.g., pull up) or reposition paraurethral support tissue, such as the perineal membrane. The perineal membrane intersects the urethra and vagina at the midurethra or distal location and can thus be stabilized or controlled in a manner that helps restore continence. As such, the implants can be utilized to eliminate the need for mesh or other supportive structures under the urethra that is common with other incontinence slings.

Claims (44)

1. A system for treating incontinence in a patient, comprising:

a first implant device having at least one non-mesh first medial anchor, a first distal anchor, and a first extension member operably connecting the at least one first medial anchor and the first distal anchor, the first medial anchor having an extendable transverse extension portion adapted to engage a portion of the perineal membrane to provide support for the urethra to restore continence; and

a second implant device separate and not physically connected, directly or indirectly, with the first implant device and having at least one non-mesh second medial anchor, a second distal anchor, and a second extension member operably connecting the second medial anchor and the second distal anchor, the second medial anchor having an extendable transverse extension portion adapted to engage a portion of the perineal membrane, separate from the portion of the perineal membrane, and at an opposing side of the urethra, engaged by the at least one first medial anchor, to assist in supporting the urethra to restore continence, and wherein the separated first and second implant devices together form a general V-shaped support configuration relative to the perineal membrane.

2. The system of claim 1 , wherein the first extension member includes a suture.

3. The system of claim 1 , wherein the first extension member is selected from a group consisting of: a braided member, an elongated mesh, a flexible rod, a rigid rod and a length-adjustable member.

4. The system of claim 1 , wherein the first distal anchor includes a first array of anchors, each of the first array of anchors having expandable barbs and being operably connected to the first extension member.

5. The system of claim 4 , further including an introduction needle having a lumen extending therethrough, wherein at least the first array of anchors are adapted to traverse the lumen in a compressed state.

6. The system of claim 1 , wherein the second distal anchor includes a second array of anchors, each of the second array of anchors having expandable barbs and being operably connected to the second extension member.

7. The system of claim 1 , wherein the at least one first medial anchor includes one or more expandable fins adapted for engagement with the portion of the perineal membrane.

8. The system of claim 1 , wherein at least the second medial anchor includes expandable fins adapted to engage the second medial anchor device to the portion of the perineal membrane separate from the portion of the perineal membrane engaged by the at least one first medial anchor.

9. The system of claim 1 , wherein the portion of the perineal membrane engaged by the at least one first medial anchor is on a side of the urethra.

10. The system of claim 1 , wherein the portion of the perineal membrane engaged by the at least one first medial anchor is generally above the urethra.

11. The system of claim 1 , wherein the portion of the perineal membrane engaged by the at least one first medial anchor is generally below the urethra.

12. The system of claim 1 , wherein the first distal anchor is adapted to engage a target tissue site selected from the group consisting of: the obturator foramen, obturator internus, abdominal fascia, sacrospinous ligament, prepubic fascia, rectus fascia, the tendinous arch of the levator ani, the Cooper's ligament, and the pubic symphysis cartilage.

13. The system of claim 1 , wherein the at least one first medial anchor or the first distal anchor include an adhesive to assist in tissue engagement.

14. The system of claim 13 , wherein the adhesive is a light-activated adhesive.

15. A system for treating incontinence in a patient, comprising:

a first implant device having a non-mesh first medial anchor and a first extension member, the first medial anchor having a pivotable radial extension portion adapted to affix to a portion of the perineal membrane of the patient on a first side of the urethra;

a second implant device separate and unconnected from, directly or indirectly, the first implant device and having a non-mesh second medial anchor and a second extension member, the second medial anchor having a pivotable radial extension portion adapted to affix to a portion of the perineal membrane of the patient on a second side of the urethra opposite the first side of the urethra, such that the separated first and second implant devices together form a general V-shaped support configuration relative to the perineal membrane; and

wherein tensioning adjustment on at least the first implant device provides support for the urethra to restore continence.

16. The system of claim 15 , wherein tensioning adjustment on the first implant device and the second implant device provides support for the urethra to restore continence.

17. The system of claim 15 , wherein at least one of the first extension member and the second extension member includes a suture.

18. The system of claim 15 , wherein at least one of the first extension member and the second extension member includes an elongate mesh.

19. The system of claim 15 , further including a first distal anchor device operably connected to the first medial anchor via the first extension member.

20. The system of claim 19 , wherein the first distal anchor device includes a first array of anchors, each of the first array of anchors having expandable barbs and being operably connected to the first extension member.

21. The system of claim 20 , further including an introduction needle having a lumen extending therethrough, wherein at least the first array of anchors are adapted to traverse the lumen in a compressed state.

22. The system of claim 19 , wherein the first distal anchor is adapted to engage a target tissue site selected from the group consisting of: the obturator foramen, abdominal fascia, rectus fascia, the tendinous arch of the levator ani, the Cooper's ligament, and the pubic symphysis cartilage.

23. The system of claim 15 , further including a second distal anchor device operably connected to the second medial anchor via the second extension member.

24. The system of claim 23 , wherein the second distal anchor device includes a second array of anchors, each of the second array of anchors having expandable barbs and being operably connected to the second extension member.

25. The system of claim 15 , wherein at least the first medial anchor device includes expandable fins adapted to affix the first medial anchor device to the portion of the perineal membrane.

26. The system of claim 15 , further including an introduction needle having a lumen extending therethrough.

27. A system for treating incontinence in a patient, comprising:

a first implant device having a non-mesh first medial anchor device, a first distal anchor device, and a first extension member operably extending between the first medial anchor device and the first distal anchor device, the first medial anchor device having one or more member portions extendable out radially therefrom and adapted to affix to a portion of the perineal membrane of the patient on a first side of the urethra and the distal anchor device adapted to affix to tissue away from the perineal membrane;

a second implant device physically separate and unconnected, directly or indirectly, with the first implant device and having a non-mesh second medial anchor device, a second distal anchor device, and a second extension member operably extending between the second medial anchor device and the second distal anchor device, the second medial anchor device having one or more member portions extendable out radially therefrom and adapted to affix to a portion of the perineal membrane of the patient on a second side of the urethra, opposite the first side of the urethra, and the second distal anchor device adapted to affix to tissue away from the perineal membrane, such that the separated first and second implant devices together form a general V-shaped support configuration relative to the perineal membrane; and

wherein tensioning adjustment on the first and second implant devices provides support for the urethra to restore continence.

28. The system of claim 27 , wherein at least one of the first extension member and the second extension member includes a suture.

29. The system of claim 27 , wherein at least one of the first extension member and the second extension member includes an elongate mesh.

30. The system of claim 27 , wherein the first distal anchor device includes a first array of anchors, each of the first array of anchors having expandable barbs and being operably connected to the first extension member.

31. The system of claim 30 , further including an introduction needle having a lumen extending therethrough, wherein at least the first array of anchors are adapted to traverse the lumen in a compressed state.

32. The system of claim 27 , wherein the second distal anchor device includes a second array of anchors, each of the second array of anchors having expandable barbs and being operably connected to the second extension member.

33. The system of claim 27 , wherein at least the first medial anchor device includes expandable fins adapted to affix the first medial anchor device to the portion of the perineal membrane.

34. The system of claim 27 , wherein at least one of the first distal anchor device and the second distal anchor device is adapted to engage a target tissue site selected from the group consisting of: the obturator foramen, abdominal fascia, rectus fascia, the tendinous arch of the levator ani, the Cooper's ligament, and the pubic symphysis cartilage.

35. The system of claim 27 , wherein at least one of the first medial anchor device and the first distal anchor device includes an adhesive to assist in tissue engagement.

36. The system of claim 35 , wherein the adhesive is a light-activated adhesive.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2012
From: ALLEN, JOHN J.; MUJWID, JAMES R.; ARNAL, KEVIN R.; FELTON, JESSICA E.; LUND, ROBERT E.
To: AMS RESEARCH CORPORATION
Reel/Frame 029403/0059 →